Luo HY - Search Results

1

Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways.

Zhou ZW, Long HZ, Xu SG, Li FJ, Cheng Y, Luo HY, Gao LC. Zhou ZW, et al. Among authors: luo hy. Front Pharmacol. 2022 May 13;13:899208. doi: 10.3389/fphar.2022.899208. eCollection 2022. Front Pharmacol. 2022. PMID: 35645817 Free PMC article. Review.

2

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease.

Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. Long HZ, et al. Among authors: luo hy. Front Pharmacol. 2021 Apr 15;12:648636. doi: 10.3389/fphar.2021.648636. eCollection 2021. Front Pharmacol. 2021. PMID: 33935751 Free PMC article. Review.

3

Isoliensinine: A Natural Compound with "Drug-Like" Potential.

Cheng Y, Li HL, Zhou ZW, Long HZ, Luo HY, Wen DD, Cheng L, Gao LC. Cheng Y, et al. Among authors: luo hy. Front Pharmacol. 2021 Apr 22;12:630385. doi: 10.3389/fphar.2021.630385. eCollection 2021. Front Pharmacol. 2021. PMID: 33967765 Free PMC article. Review.

4

Isoliensinine induces cervical cancer cell cycle arrest and apoptosis by inhibiting the AKT/GSK3α pathway.

Li HL, Cheng Y, Zhou ZW, Long HZ, Luo HY, Wen DD, Cheng L, Gao LC. Li HL, et al. Among authors: luo hy. Oncol Lett. 2022 Jan;23(1):8. doi: 10.3892/ol.2021.13126. Epub 2021 Nov 9. Oncol Lett. 2022. PMID: 34820007 Free PMC article.

5

From Microbiome to Inflammation: The Key Drivers of Cervical Cancer.

Zhou ZW, Long HZ, Cheng Y, Luo HY, Wen DD, Gao LC. Zhou ZW, et al. Among authors: luo hy. Front Microbiol. 2021 Nov 15;12:767931. doi: 10.3389/fmicb.2021.767931. eCollection 2021. Front Microbiol. 2021. PMID: 34867901 Free PMC article. Review.

6

The key roles of organelles and ferroptosis in Alzheimer's disease.

Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. Long HZ, et al. Among authors: luo hy. J Neurosci Res. 2022 Jun;100(6):1257-1280. doi: 10.1002/jnr.25033. Epub 2022 Mar 16. J Neurosci Res. 2022. PMID: 35293012 Review.

7

The Role of Microglia in Alzheimer's Disease From the Perspective of Immune Inflammation and Iron Metabolism.

Long HZ, Zhou ZW, Cheng Y, Luo HY, Li FJ, Xu SG, Gao LC. Long HZ, et al. Among authors: luo hy. Front Aging Neurosci. 2022 Jun 30;14:888989. doi: 10.3389/fnagi.2022.888989. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35847685 Free PMC article. Review.

8

Pharmacokinetics, Bioequivalence, and Safety of 2 Formulations of Hydroxychloroquine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Luo HY, Long HZ, Zhou ZW, Xu SG, Li FJ, Cheng Y, Wen DD, Deng P, Gao LC. Luo HY, et al. Clin Pharmacol Drug Dev. 2023 Mar;12(3):273-278. doi: 10.1002/cpdd.1166. Epub 2022 Sep 1. Clin Pharmacol Drug Dev. 2023. PMID: 36047047 Clinical Trial.

9

System X_c ^-/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy.

Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC. Li FJ, et al. Among authors: luo hy. Front Pharmacol. 2022 Aug 29;13:910292. doi: 10.3389/fphar.2022.910292. eCollection 2022. Front Pharmacol. 2022. PMID: 36105219 Free PMC article. Review.

10

Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.

Luo HY, Long HZ, Zhou ZW, Xu SG, Li FJ, Cheng Y, Wen DD, Deng P, Gao LC. Luo HY, et al. Drugs R D. 2022 Dec;22(4):311-320. doi: 10.1007/s40268-022-00406-2. Epub 2022 Nov 11. Drugs R D. 2022. PMID: 36369609 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

539 results

Search Page